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Original Article
Can adjuncts to bowel preparation for
colonoscopy improve patient experience
and result in superior bowel cleanliness?
A systematic review and meta-analysis
Umair Kamran1, Abdullah Abbasi2, Imran Tahir3, James Hodson4
and Keith Siau1,5
Abstract
Background: Bowel preparation for colonoscopy is often poorly tolerated due to poor palatability and adverse
effects. This can negatively impact on the patient experience and on the quality of bowel preparation. This sys-
tematic review and meta-analysis was carried out to assess whether adjuncts to bowel preparation affected
palatability, tolerability and quality of bowel preparation (bowel cleanliness).
Methods: A systematic search strategy was conducted on PubMed, MEDLINE, EMBASE and the Cochrane Database
of Systematic Reviews to identify studies evaluating adjunct use for colonoscopic bowel preparation. Studies
comparing different regimens and volumes were excluded. Specific outcomes studied included palatability
(taste), willingness to repeat bowel preparation, gastrointestinal adverse events and the quality of bowel prepa-
ration. Data across studies were pooled using a random-effects model and heterogeneity assessed using
I2-statistics.
Results: Of 467 studies screened, six were included for analysis (all single-blind randomised trials; n¼ 1187
patients). Adjuncts comprised citrus reticulata peel, orange juice, menthol candy drops, simethicone, Coke Zero
and sugar-free chewing gum. Overall, adjunct use was associated with improved palatability (mean difference 0.62,
95% confidence interval 0.29–0.96, p< 0.001) on a scale of 0–5, acceptability of taste (odds ratio 2.75, 95% con-
fidence interval: 1.52–4.95, p< 0.001) and willingness to repeat bowel preparation (odds ratio 2.92, 95% confidence
interval: 1.97–4.35, p< 0.001). Patients in the adjunct group reported lower rates of bloating (odds ratio 0.48, 95%
confidence interval: 0.29–0.77, p¼ 0.003) and vomiting (odds ratio 0.47, 95% confidence interval 0.27–0.81,
p¼ 0.007), but no difference in nausea (p¼ 0.10) or abdominal pain (p¼ 0.62). Adjunct use resulted in superior
bowel cleanliness (odds ratio 2.52, 95% confidence interval: 1.31–4.85, p¼ 0.006). Heterogeneity varied across
outcomes, ranging from 0% (vomiting) to 81% (palatability), without evidence of publication bias. The overall
quality of evidence was rated moderate.
Conclusion: In this meta-analysis, the use of adjuncts was associated with better palatability, less vomiting and
bloating, willingness to repeat bowel preparation and superior quality of bowel preparation. The addition of
adjuncts to bowel preparation may improve outcomes of colonoscopy and the overall patient experience.
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What is already known?
Bowel preparation is often poorly tolerated due to its taste and side effects which can result in inadequate
colonoscopic examination and poor patient experience.
What is new here?
The use of adjuncts with bowel preparation was associated with improved patient experience and better quality of
bowel cleanliness.
Introduction
Colonoscopy is the gold standard modality for investi-
gating the lower gastrointestinal tract with approxi-
mately one million procedures performed in the
United Kingdom each year.1 Despite the intrusive
nature of the procedure, many patients perceive the
consumption of pre-procedural bowel preparation to
be the most burdensome aspect of colonoscopy,2,3
with poor palatability (taste) being a major challenge.4
Issues with palatability can result in nausea, failure to
complete the prescribed regimen and a negative expe-
rience prior to colonoscopy. In turn, this may impact
on mucosal views, procedural completion and missed
lesions during colonoscopy. As such, improving the
palatability of bowel preparation may improve patient
acceptance of colonoscopy and other patient-centred
outcomes.
Currently, most bowel preparation regimens instruct
the use of water as the solvent of choice. Recent data
suggest the role of alternatives to water as a solvent for
bowel preparation, with improvements in patient toler-
ability profiles and on mucosal visualisation.4 We
therefore performed a systematic review and meta-
analysis with the aim of evaluating whether the palat-
ability (taste) and tolerability of bowel preparation
may be improved through the use of adjuncts, e.g. fla-
vour enhancers or alternatives to water. In addition, we
aimed to assess whether these adjuncts may impact on
additional patient-based outcomes, e.g. gastrointestinal
adverse events, willingness to repeat bowel preparation,
quality of bowel preparation (bowel cleanliness).
Methods
Study design
This was a systematic review and meta-analysis of stud-
ies reporting on adjuncts which affect the palatability
and tolerability of bowel preparation in patients under-
going colonoscopy. We defined adjunct as an agent
taken in conjunction with bowel preparation to
improve palatability (taste). The systematic review
was prospectively registered on The International
Prospective Register of Systematic better known as
PROSPERO (ID: CRD42020162201) and complies
with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) protocol.
Ethical approval was not required for this systematic
review.
Inclusion and exclusion criteria
Study types eligible for inclusion comprised full-text
publications of randomised controlled trials, cohort
and case-controlled studies. Studies were eligible if
data were included on the primary outcome and if
they had compared adjuncts standard bowel prepa-
ration in the intervention arm vs standard bowel prep-
aration (with water) in the control arm. An adjunct was
defined as an agent used in conjunction with bowel
preparation to improve its palatability. Results were
restricted to full-text articles in English.
To restrict the effect studied to adjuncts alone,
studies with different dosing regimens or different
total volumes of solution in the intervention and con-
trol groups were excluded. For example, studies com-
paring 2 litre (L) polyethylene glycol (PEG) with
adjunct vs 4L PEG without the adjunct would be
excluded. Studies centred on non-colonoscopic proce-
dures e.g. flexible sigmoidoscopy, Computed
Tomography (CT)-colonography, capsule endoscopy
or those exclusively enrolling children (<16 years)
were also excluded.
Search strategy
A search strategy was designed based on the Patient,
Intervention, Comparator and Outcome (PICO)
format. Searches were conducted by two independent
researchers (UK and AA) in April 2020 on PubMed,
MEDLINE, EMBASE and the Cochrane Database of
Systematic Reviews using variations and combinations
of the following keywords: bowel preparation, colonos-
copy, adjunct, addition, flavour, diluent and solvent
(Supplementary Material Figure 1). References within
2 United European Gastroenterology Journal 0(0)
cited papers were also screened for relevant publica-
tions using a snowballing approach.
Outcomes
The primary outcome studied was the palatability of
bowel preparation as measured by: (a) patient’s per-
ceived rating of bowel preparation, and (b) willingness
to repeat bowel preparation in future.
The secondary outcomes included the following: (a)
tolerability, i.e. gastrointestinal adverse events (e.g.
nausea or vomiting) arising from the bowel preparation,
and (b) adequate quality of bowel preparation, as mea-
sured using a validated mucosal visualisation scale.
Data extraction
Data extraction fields included: first author, year of
publication, country where study was performed
(or of first author), study design, size of the adjunct
and control group, description of bowel preparation
regimen and volume, outcomes studied and the n or
summary statistic in intervention vs comparator
group for each study outcome.
Bias assessment
The risk of bias was assessed using the Cochrane risk of
bias tool. This was independently assessed by two
investigators (IT, AA) and discrepancies were adjudi-
cated via the senior author (KS).
Studies identified through searching
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram demonstrating study-
selection process based on inclusion and exclusion criteria.
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Data synthesis
Studies meeting the inclusion criteria were analysed
using random-effects meta-analysis models. Separate
analyses were performed for each of the outcomes
being considered. In the case of continuous outcomes,
such as those measured on visual analogue scales,
where means and standard deviations (SDs) were
reported, analyses were performed using random-
effects inverse-variance models. Dichotomous variables
were presented as odds ratio (OR) with 95% confidence
interval (CI) and continuous data reported as mean
difference (MD) with 95% CI. Estimates of OR and
MD were pooled using a random-effects Mantel-
Haenszel model. Heterogeneity was assessed using the
I2-statistic.
Meta-regression models were then produced to esti-
mate the effect of each subgroup of adjunct or bowel
preparation separately, and to enable comparisons
between these. All analyses were performed using
Review Manager 5.3 (Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2014).
Results
Included studies
In total, the search strategy yielded 467 studies. After
exclusions (Figure 1), six studies (n¼ 1187 patients)
were included for analysis.5–10 All of these were rand-
omised controlled trials (RCTs), conducted between
2012–2016, which analysed the impact of adjuncts on
the tolerability and quality of PEG-based bowel prep-
aration. Adjuncts comprised citrus reticulata peel,6
orange juice,7 menthol candy drops,8 simethicone,5
Coke Zero9 and sugar-free chewing gum.10 Only one
study9 compared different solvents whilst the rest used
adjuncts in addition to standard bowel preparation reg-
imens. Study characteristics, including details of the
adjuncts, bowel preparation doses and timings are
summarised in Table 1.
Impact on palatability
Palatability (taste) of bowel preparation was measured
on a continuous visual analogue scale (VAS) in four
studies5,7–9 and as a categorical outcome (acceptable
taste) in two studies.6,10 One study applied an inverted
scale from four to one9 which required transformation
to enable data synthesis.
Palatability. Using an adjusted VAS of one (very low)
to five (excellent palatability), pooled palatability
scores were significantly higher in the adjunct group,
with a mean difference of 0.62 (95% CI: 0.29–0.96,
p< 0.001) compared to the control arm (Figure 2(a)).
The I2 statistic was 81% indicating considerable
heterogeneity.
Acceptable taste. The percentage of patients who rated
their bowel preparation as having acceptable taste
(Figure 2(b)) was significantly higher (OR 2.75, 95%
CI: 1.52–4.95, p< 0.001) in the adjunct group (92.5%)
vs control group (82.5%), with no significant heteroge-
neity detected (I2¼ 0%).
Willingness to repeat bowel preparation. The propor-
tion of patients willing to undergo repeat bowel prep-
aration in future was reported in five studies (Figure 2
(c)), of which four ascertained outcomes prior to colo-
noscopy.6–8,10 This outcome was significantly higher
(OR 2.92, 95% CI: 1.97–4.35, p< 0.001) in the adjunct
group (84.9%) vs control group (61.9%). No signifi-
cant heterogeneity was detected in this analysis
(I2¼ 10%).
Impact on tolerability
Five studies (n¼ 887) compared tolerability in terms of
nausea, vomiting, bloating and abdominal pain
between adjunct and control (standard bowel prepara-
tion) groups.5–9 All of these side-effects were recorded
as categorical variables. One study10 was excluded as
outcome data were presented as a composite of abdom-
inal pain, bloating and nausea with a corresponding
adverse event rate of 41.3% vs 46% (p¼ 0.42) between
two groups.
Nausea. Rates of nausea (Figure 3(a)) were not found
to differ significantly between the adjunct and control
groups (OR 0.64, 95% CI: 0.37–1.10, p¼ 0.10). There
was evidence of moderate heterogeneity (I2¼ 65%) in
this analysis.
Vomiting. Rates of vomiting (Figure 3(b)) were found
to be significantly lower in the adjunct group (4.6%) vs
control (9.3%) group (OR 0.47, 95% CI: 0.27–0.81,
p¼ 0.007). No heterogeneity was identified in this anal-
ysis (I2¼ 0%).
Bloating. Rates of bloating (Figure 3(c)) were found to
be significantly lower in the adjunct group (38.4%) vs
control (51.8%) group (OR 0.48, 95% CI: 0.29–0.77,
p¼ 0.003). The I2-statistic was 47% indicating moder-
ate heterogeneity.
Abdominal pain. Rates of abdominal pain (Figure 3(d))
were not found to differ significantly between adjunct
and control groups (OR 0.79, 95% CI: 0.31–1.99,
p¼ 0.62). There was considerable heterogeneity in this
analysis (I2¼ 76%).
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Impact on quality of bowel preparation
Five studies5–9 reported the quality of bowel prepara-
tion as the proportion of patients with acceptable or
satisfactory bowel preparation, which permitted pool-
ing of this outcome across different studies, despite
differences in use of bowel preparation scores between
studies. Minor or no bowel staining as assessed by an
endoscopist and two nurses,9 Boston Bowel
Preparation Scale 6,5 Aronchick scale 2,7 good or
excellent grading on modified Aronchick scale,8 grade
1–3 (out of Grade 1–5) for evaluating bowel cleansing6
were categorised as adequate bowel preparation.
Addition of adjuncts resulted in a higher overall pro-
portion of patients with acceptable bowel cleanliness
(92.0% vs 80.9%; OR 2.52; 95% CI: 1.31–4.85,
p¼ 0.006) (Figure 4). Heterogeneity was moderate
(I2¼ 49%). The study by Fang et al. was excluded
from this analysis as it reported the outcome as a
continuous variable using the Boston bowel prepara-
tion scale. This study found no significant difference
(p¼ 0.51) between adjunct and control groups, with
median scores of 6.1 and 6.2 respectively.10
Subgroup/sensitivity analyses
As per protocol, subgroup analyses were initially
planned to compare different types of adjuncts, i.e. fla-
vour enhancers vs alternative solvents to water.
However, only one study had replaced water with
another solution, i.e. Coke-Zero.9 Sensitivity analysis
after excluding this study did not affect the conclusions
of results or heterogeneity estimates. Although a meta-
regression comparison was intended between studies
with an improvement in palatability vs those that did
not, no studies were identified for the latter. As such,
subgroup comparisons were not performed.
YearWeight IV, Random, 95% CI
Adjunct Control Mean Difference
IV, Random, 95% CI
Mean Difference
Heterogeneity: Tau2 = 0.09; Chi2 = 16.10, df = 3 (p = 0.001); I2 = 81%
Test for overall effect: Z = 3.65 (p = 0.0003)
Heterogeneity: Tau2 = 0.00; Chi2 = 0.40, df = 1 (p = 0.53); I2 = 0%
Test for overall effect: Z = 3.36 (p = 0.0008)
Study or Subgroup Mean Total TotalMeanSD SD
(a)
Adjunct
Study or Subgroup Events EventsTotal Total Weight YearM–H, Random, 95% CI
Control Odds Ratio





















Heterogeneity: Tau2 = 0.02; Chi2 = 4.46, df = 4 (p = 0.35); I2 = 10%
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1.88  [1.08, 3.25]
4.98  [1.83, 13.54]









































































YearM–H, Random, 95% CI
Adjunct Control Odds ratio
M–H, Random, 95% CI
Odds ratio
Study or Subgroup Events Total Total WeightEvents
(b)
–2
0.05 0.2 1 5 20
0.05 0.2 1 5 20
–1 0 1 2
Figure 2. Pooled analyses for palatability score (a), bowel preparation rated as acceptable (b) and willingness to take bowel
preparation in future (c).
CI: confidence interval; SD: standard deviation; IV: Inverse variance model; MH: Mantel-Haenszel model.
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Quality of evidence
All included studies were single-blinded RCTs. The risk
of bias from most of the included RCTs were low
(Figure 5), with the exception of allocation of
concealment (selection bias) and blinding of
participants due to the nature of studies involving fla-
vour enhancers.
Funnel plots were then produced and analysed for
pooled outcome comparisons. There was no evidence
of publication bias from the included studies
Adjunct
Study or Subgroup Events EventsTotal Total Weight YearM–H, Random, 95% CI
Control Odds Ratio





















Heterogeneity: Tau2 = 0.24; Chi2 = 11.51, df = 4 (p = 0.02); I2 = 65%
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1.10  [0.67, 1.81]
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Adjunct
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Heterogeneity: Tau2 = 0.00; Chi2 = 1.51, df = 4 (p = 0.89); I2 = 0%
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Adjunct
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0.71  [0.33, 1.54]
0.67  [0.29, 1.52]
0.81  [0.27, 2.41]
0.26  [0.15, 0.44]
0.48  [0.29, 0.77]
Adjunct
Study or Subgroup Events EventsTotal Total Weight YearM–H, Random, 95% CI
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Heterogeneity: Tau2 = 0.84; Chi2 = 16.64, df = 4 (p = 0.002); I2 = 76%

























3.01  [0.93, 9.79]
0.62  [0.23, 1.67]
1.03  [0.38, 2.74]
0.18  [0.08, 0.43]
1.10  [0.37, 3.24]
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0.1 0.2 0.5 1
Favours adjunct       Favours control
2 5 10
0.1 0.2 0.5 1
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2 5 10
0.1 0.2 0.5 1
Favours adjunct    Favours control
2 5 10
0.1 0.2 0.5 1
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2 5 10
Figure 3. Pooled analyses for tolerability (gastrointestinal adverse events). Nausea (a), vomiting (b), bloating (c) and abdominal
pain (d).
CI: confidence interval; M-H: Mantel-Haenszel.
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(Supplementary Material Figure 2) for the major
outcomes studied.
Discussion
In this meta-analysis of six RCTs, the use of adjuncts
with bowel preparation for colonoscopy was associated
with significant improvements in palatability, as mea-
sured by the pooled rates of palatability score, accept-
able taste and willingness to repeat bowel preparation.
Adverse events of vomiting and bloating, but not
nausea and abdominal pain, occurred less frequently
in the adjunct group. Overall, adequate quality of
bowel preparation was more likely to be achieved in
the adjunct group compared to controls.
Our findings have direct implications for patients
undergoing colonoscopy. First, taste is one of the
most burdensome aspects of taking bowel
preparation.4 In a study by Sharara et al., this was
rated by patients as second only to the volume of
bowel preparation, with 41.5% assigning a score of
7þ (on a VAS of 0–10 from best to worst) for PEG-
based split dose regimens,4 which are recommended by
the European Society of Gastrointestinal Endoscopy
(ESGE)11 and used in three of the six included studies.
In our analysis, palatability scores and rates of accept-
able taste were superior in the adjunct group. Second,
patients undergoing colonoscopy may have pre-existing
gastrointestinal complaints/complications that can be
aggravated by bowel preparation. Vomiting is particu-
larly unpleasant and can arise from noxious stimuli
from the gustatory response to bowel preparation.12
Importantly, the use of adjuncts reduced the pooled
adverse event rates of vomiting (9.3% to 4.6%) and
bloating (50.3% to 36.2%). Third, high-quality bowel
Adjunct
Study or Subgroup Events EventsTotal Total Weight YearM–H, Random, 95% CI
Control Odds Ratio
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2.54  [1.24, 5.21]
12.33  [2.83, 53.77]
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0.05 0.2 1 5 20
Favours control     Favours adjunct
Figure 4. Pooled analyses for adequacy of bowel preparation.
CI: confidence interval; M-H: Mantel-Haenszel.
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Figure 5. Risk of bias tables.
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preparation underpins high-quality colonoscopy.13
Adequate bowel preparation was more likely to be
achieved in the adjunct group (92.0% vs 80.9%,
p¼ 0.006), and probably reflects better tolerability, as
poor palatability or vomiting can lead to non-
completion of bowel preparation.14 In a French
survey of 1.12 million colonoscopies, 2% of procedures
were repeated due to inadequate bowel preparation.15
Improved tolerability may reduce the need for repeat
procedures, especially in frailer patients. Finally, the
proportion of patients willing to repeat bowel prepara-
tion was higher in the adjunct group (84.9% vs 69.1%).
This may be particularly beneficial to patients with
incomplete examinations or those requiring regular
screening or surveillance colonoscopies (e.g. polyp or
inflammatory bowel disease surveillance), where long-
term patient engagement and compliance is essential.
To our knowledge, only one meta-analysis has been
published by Restellini et al.16 which evaluated the role
of adjuncts as a secondary analysis. However, the
authors included studies comparing different regimens
and volumes of bowel preparation and therefore could
not attribute the reported benefits to adjuncts alone.
Our meta-analysis provides novelty as it addresses the
issue of confounding by including studies only where
bowel preparation regimens and volumes are compara-
ble between intervention and control arms. We also
excluded studies which assessed flavour-enhancing
adjuncts such as Gatorade,17,18 olive oil,19 pineapple
juice20 and coffee21 due to our exclusion criteria
(mainly due to differences in bowel preparation vol-
umes). This was also the case with ascorbic acid,
which is a commonly used adjunct. The addition of
ascorbic acid to low-volume PEG solution (2L) has
been shown to improve taste22 and provides similar
efficacy in comparison to PEG with 4L solution,23,24
but these studies did not fulfil eligibility criteria due to
differences in PEG volumes, and hence were not
included in our meta-analysis. Despite this, pooled
effects in favour of patient benefit were demonstrated
in most of our studied outcomes, without evidence of
publication bias. It is possible that adjuncts do have a
role in modulating or counteracting the unfavourable
taste profile of conventional bowel preparation.25
Our study had several limitations. First, we applied
strict selection criteria which led to only six eligible
RCTs. There was insufficient data to allow for mean-
ingful subgroup analyses, e.g. by type of adjunct or
alternatives to water, or by type of bowel preparation
or for additional outcomes which had been specified
a priori, e.g. adenoma detection rates, hence our devi-
ation from our registered protocol. Second, the hetero-
geneity of RCTs was variable between outcomes
(ranging between 0–80þ%) which reflects the differen-
ces in the adjuncts studied and reporting of outcomes.
This will affect data interpretation. As it is obvious that
the adjuncts studied were not the same, the benefit
cannot be attributable to any flavour-enhancing
adjunct, but regarded as a generalised concept of ben-
efit in carefully selected adjunct methods. We also
acknowledge the differences in bowel preparation
used between studies (Table 1), which reflects varia-
tions in usage worldwide and may contribute to hetero-
geneity between studies. However, this is negated by
our study design, which was intended to study the
effect of adjuncts independent of the bowel preparation
regimens used. Third, the choice and measurement of
outcomes varied across studies. This precluded the abil-
ity to pool outcome data across all six studies.
Moreover, the willingness to retake bowel preparation
may be a composite measure of palatability, tolerability
and potentially encompasses the patient experience of
colonoscopy, rather than being attributable to palat-
ability alone. Finally, all studies were single-blinded
and vulnerable to concealment bias as it was not pos-
sible to blind participants to taste.
Many patients and healthcare professionals hold the
misconception that bowel preparation should only be
used with water. Patient education is key to attaining
good quality bowel preparation.26 Our meta-analysis
shows that adjuncts can be used with bowel prepara-
tion in a safe manner without compromising mucosal
visualisation but, conversely, increase bowel cleanliness
by enhancing palatability and tolerability. This may
have implications for the patient perception of colonos-
copy and may improve compliance with colonoscopy
attendance.
Conclusion
In this meta-analysis, use of adjuncts with bowel prep-
aration was associated with better palatability, less
vomiting and bloating, and superior bowel cleanliness.
Adjuncts may be used with bowel preparation to
improve the overall patient experience and outcomes
of colonoscopy.
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